NCT03181841 Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals Status COMPLETED Phase PHASE1
NCT03178071 Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive Status NO_LONGER_AVAILABLE Phase N/A
NCT03170609 A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age Status COMPLETED Phase PHASE2
NCT03170206 Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT03164291 Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex Status COMPLETED Phase PHASE3
NCT03162900 A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects Status COMPLETED Phase PHASE1
NCT03159936 Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Status TERMINATED Phase EARLY_PHASE1
NCT03159117 Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT03148795 A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT03147287 Palbociclib After CDK and Endocrine Therapy (PACE) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03146065 Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512 Status COMPLETED Phase PHASE1
NCT03142711 Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase N/A
NCT03140176 Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy. Status TERMINATED Phase N/A
NCT03137368 A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP) Status UNKNOWN Phase PHASE3
NCT03137134 A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation. Status COMPLETED Phase PHASE1
NCT03135834 A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. Status COMPLETED Phase PHASE3
NCT03130556 A Study Of Glasdegib In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The ICH Formulation Status COMPLETED Phase PHASE1
NCT03128411 Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE2